These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2875933)

  • 1. The molecular genetics of hyperlipidemia.
    Shoulders CC; Baralle FE
    Horiz Biochem Biophys; 1986; 8():299-340. PubMed ID: 2875933
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24.
    Wojciechowski AP; Farrall M; Cullen P; Wilson TM; Bayliss JD; Farren B; Griffin BA; Caslake MJ; Packard CJ; Shepherd J
    Nature; 1991 Jan; 349(6305):161-4. PubMed ID: 1670899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotypes identified by DNA restriction-fragment-length polymorphisms in the A-1 C-III A-IV gene region and hypertriglyceridemia.
    Stocks J; Paul H; Galton D
    Am J Hum Genet; 1987 Aug; 41(2):106-18. PubMed ID: 2887109
    [No Abstract]   [Full Text] [Related]  

  • 4. The association between primary gout and hypertriglyceridaemia may be due to genetic linkage.
    Ferns GA; Lanham J; Galton DJ
    Monogr Atheroscler; 1985; 13():121-3. PubMed ID: 3937047
    [No Abstract]   [Full Text] [Related]  

  • 5. Cloning of apoprotein AI gene and observation on DNA polymorphism of apoprotein AI/CIII gene-loci in genomic library from a liver of Chinese.
    Xu HJ; Zhou HY; Hu SX; Pan XR
    Chin Med J (Engl); 1989 Mar; 102(3):169-73. PubMed ID: 2569382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA polymorphisms in and around the Apo-A1-CIII genes and genetic hyperlipidemias.
    Hayden MR; Kirk H; Clark C; Frohlich J; Rabkin S; McLeod R; Hewitt J
    Am J Hum Genet; 1987 May; 40(5):421-30. PubMed ID: 2883893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetics and molecular biology.
    Chamberlain JC
    Curr Opin Lipidol; 1997 Oct; 8(5):U63-4. PubMed ID: 9335960
    [No Abstract]   [Full Text] [Related]  

  • 9. A mouse model with features of familial combined hyperlipidemia.
    Masucci-Magoulas L; Goldberg IJ; Bisgaier CL; Serajuddin H; Francone OL; Breslow JL; Tall AR
    Science; 1997 Jan; 275(5298):391-4. PubMed ID: 8994037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III.
    Dallinga-Thie GM; Bu XD; van Linde-Sibenius Trip M; Rotter JI; Lusis AJ; de Bruin TW
    J Lipid Res; 1996 Jan; 37(1):136-47. PubMed ID: 8820109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and familial dyslipidaemias.
    Ascaso JF; Real JT; Carmena R
    Diabetes Obes Metab; 1999 Nov; 1(6):323-30. PubMed ID: 11225648
    [No Abstract]   [Full Text] [Related]  

  • 12. Disorders of lipid transport: relationship to abnormalities of apoproteins, enzymes and cellular receptors.
    Schonfeld G
    Prog Clin Biol Res; 1984; 147():375-402. PubMed ID: 6330755
    [No Abstract]   [Full Text] [Related]  

  • 13. Apolipoprotein AI-CIII gene polymorphisms in Japanese myocardial infarction survivors.
    Satoh J; Hattori N; Onuki M; Yamakawa K; Fujiwara H; Amamiya H; Nagaoka H; Sakuma T; Yamanouchi Y; Okafuji T
    Jinrui Idengaku Zasshi; 1987 Mar; 32(1):15-20. PubMed ID: 2886684
    [No Abstract]   [Full Text] [Related]  

  • 14. A DNA polymorphism of the apoprotein AII gene in hypertriglyceridaemia.
    Ferns GA; Shelley CS; Stocks J; Rees A; Paul H; Baralle F; Galton DJ
    Hum Genet; 1986 Nov; 74(3):302-6. PubMed ID: 2877939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of familial hypercholesterolemia using DNA haplotype analysis in three large families with two hyperlipidemic parents.
    Schuster H; Keller C; Wolfram G; Zöllner N
    Ann Nutr Metab; 1992; 36(2):79-86. PubMed ID: 1354952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.
    Cardona F; Tinahones FJ; Collantes E; Escudero A; García-Fuentes E; Soriguer FJ
    Ann Rheum Dis; 2005 Jan; 64(1):85-8. PubMed ID: 15115711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants of the lipoproteins and hyperlipidaemia.
    Galton DJ; Stocks J; Rees A
    Biochem Soc Trans; 1985 Feb; 13(1):31-4. PubMed ID: 3922820
    [No Abstract]   [Full Text] [Related]  

  • 19. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic basis for hypertriglyceridaemia in familial combined hyperlipidaemia.
    Erkelens DW
    Eur Heart J; 1998 Jul; 19 Suppl H():H23-6. PubMed ID: 9717061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.